Log In
Print this Print this

flutiform K-Haler

  Manage Alerts
Collapse Summary General Information
Company Vectura Group plc
DescriptionBreath-actuated version of flutiform, a fixed-dose combination of formoterol, a long-acting adrenergic receptor beta 2agonist (LABA), and fluticasone propionate, an inhaled corticosteroid, delivered via a breath-activated pressurized metered dose inhaler
Molecular Target Adrenergic receptor beta 2 (ADRB2) ; Glucocorticoid receptor (GCCR)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentRegistration
Standard IndicationAsthma
Indication DetailsTreat asthma in adolescents and adults
Regulatory Designation
PartnerMundipharma International Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today